Search

The European TINNET COST Action BM1306

Winfried Schlee describes how a major European funding award is bringing together experts who are committed to collectively developing a better understanding of tinnitus. This work is vital if we are to pioneer effective treatments for the condition in its...

Outcome measurements WG5. Developing a core outcome set of measures for tinnitus

Alain Londero presents a large-scale collaboration that invites clinicians and patients to develop a minimum standard for assessing the efficacy of tinnitus treatments. This will become an international recommendation for all clinical trials of tinnitus. WG5 is working towards a...

Conspiring together: tinnitus and hearing loss

In this special feature, Nic Wray of the British Tinnitus Association and Zheng Yen Ng of The Ear Foundation present the results of their report into managing tinnitus for people with hearing loss. In September 2015, the British Tinnitus Association...

The future of hearing care and the role of audiology

The Clinical Director of Cincinnati Children’s Hospital Medical Center and President-elect of the American Academy of Audiology reviews the status of the present day audiologist’s remit, and discusses the changes we can expect with the changing demographic and behaviour of...

What’s new in genetic testing for hearing impairment?

Often the first question following the diagnosis of a hearing loss is ‘why?’ In this article Ali Danesh explores the advances made in uncovering ‘why’ from a genetics perspective. Ali describes the panel of genetic tests now commercially available to...

What’s new in hearing aid technology? Requisites for successful implementation of eHealth in hearing health care

Like Eeyore in AA Milne’s Winnie the Pooh stories it appears we all will soon have a personal cloud, but unlike Eeyore this will be something to celebrate! The future of hearing aid technology is in the cloud argues Uwe...

A place for everything and everything in its place: the practicalities of randomised clinical trials

Will this pill cure tinnitus? Bonnie Millar describes one trial that has investigated the possibility whilst describing the path of drug trials in the UK. Background In the last quarter of 2014, a clinical trial (QUIET-1; ClinicalTrials.gov Identifier: NCT02315508) commenced...

Thyroid dysfunction and Meniere’s disease: is there a relationship?

The set of symptoms described as Meniere’s disease may have several causative factors. Timothy Hain and Patthida Maroongroge look for a relationship in the literature between Meniere’s disease and hypothyroidism. Meniere’s disease (MD) affects around two in 1000 people and...

Infant hearing loss impacts spoken language development: identify and intervene early

Early hearing detection and intervention programmes have been implemented in many countries across the globe, but why are these programmes so important and how are our Canadian colleagues managing this process? The consequences of being born with a permanent hearing...

Collaborating with patients on research priorities in hyperacusis: the James Lind Alliance project

An innovative and inclusive approach to the identification and prioritisation of research questions is to place the views of patients at the heart of the process, and in partnership with clinicians. The application of this to hyperacusis is described by...

TEN testing in paediatric patients

Threshold equalising noise (TEN) testing is used to identify dead regions (DRs) of the cochlear. Alexandra Lusty considers the challenges of using the TEN test in the paediatric population as well as the importance of identifying DRs. Diagnosing dead regions...

Hearing aids 2019: today’s technology

High-end or basic hearing aids: does the technology level make a difference? Catherine Palmer shares the current evidence base and suggests where hearing healthcare professionals can make the most impact. The most common complaint from individuals with mild-to-moderately severe hearing...